Williams-Hall, Rebecca http://orcid.org/0000-0001-9530-0505
Trennery, Claire http://orcid.org/0000-0002-9406-5096
Sully, Kate
Wratten, Samantha http://orcid.org/0000-0003-0552-181X
Francis, Anya http://orcid.org/0000-0002-1026-7265
Chandler, Dale http://orcid.org/0000-0001-8840-4963
Flynn, Jessica http://orcid.org/0000-0002-4461-2610
Turner, Megan http://orcid.org/0000-0002-8624-8108
Marks, Daniel J. B. http://orcid.org/0000-0003-3805-6328
Sackeyfio, Alfred
Bracher, Marguerite
Walker, Alex http://orcid.org/0000-0002-8482-7499
Walker-Nthenda, Louise http://orcid.org/0000-0003-4280-195X
Arbuckle, Rob http://orcid.org/0000-0003-0345-2523
Keeley, Tom http://orcid.org/0000-0003-1584-9093
Funding for this research was provided by:
GlaxoSmithKline
Article History
Accepted: 6 August 2022
First Online: 2 September 2022
Declarations
:
: RW-H, KS, AF, JF, and RA are employees of Adelphi Values which was contracted by GlaxoSmithKline (GSK) to conduct the study. SW and DC were employees of Adelphi Values at the time the study was conducted. CT was an employee of Adelphi Values at the time the study was conducted and is now an employee of and stockholder in GSK. MT, AS, AW, LW-N, and TK are employees of and stockholders in GSK. DJBM was an employee of GSK at the time of conduct of the study, is currently an employee of AstraZeneca, and is a stockholder in GSK and AstraZeneca.
: The study was approved by an independent scientific review committee (The Copernicus Group, Cary, NC; IRB tracking number: 20190635, IRB amendment tracking number 20190635). All patients and clinicians provided verbal and written informed consent to participate in the study. Written permission was obtained from the parents/guardians of adolescent patients and written assent was obtained from the adolescents.
: Yes, the participants provided verbal and written informed consent to participate prior to study initiation.
: N/A.